Home
Dashboard
Growth Program
Growth VC
Curated content
Startups & Scaleups
Corporates
Job board
Investors
Transactions
More organizations
Matching tool
Investment heatmap
Companies
Lysosomal Therapeutics
Save
Lysosomal Therapeutics
Delivering cures for neurodegenerative diseases.
Launch date
2014
Employees
1 people
Market cap
-
Enterprise valuation
$80—120m
(Dealroom.co estimates Feb 2015.)
Cambridge Massachusetts (HQ)
http://www.lysosomaltx.com
https://www.linkedin.com/company/lysosomal-therapeutics-inc.
B2B
manufacturing
health
biotechnology
hard tech
biotechnology
biotech and pharma
neurology
Overview
Similar companies
Investments (3)
Analytics
Notes
Job openings
Innovations (0)
Patents (5)
Lysosomal Therapeutics funding
Lysosomal Therapeutics investors
Edit
Date
Investors
Amount
Round
-
Sanofi Ventures
N/A
-
May 2014
Atlas Venture
$4.8m
Seed
Feb 2015
Atlas Venture
$20.0m
Series A
Jan 2017
Allergan
N/A
Acquisition
Total Funding
$24.8m
Related Content
Recent News about Lysosomal Therapeutics
Edit
Tech stack
Group
Tech stack
Learn more about the technologies and tools that this company uses.
Login for access
Investments by Lysosomal Therapeutics
Edit
Artax Biopharma
NanoString Technologies
ACQUISITION by Bruker Apr 2024
Amylyx Pharmaceutical
exited
